NCT01290393 is a clinical trial of Data collection in Infections, Papillomavirus, sponsored by GlaxoSmithKline.

Who is sponsoring NCT01290393?

NCT01290393 is sponsored by GlaxoSmithKline.

What drugs are being tested in NCT01290393?

Interventions in NCT01290393: Data collection.

What condition does NCT01290393 study?

NCT01290393 studies Infections, Papillomavirus.

Is NCT01290393 still recruiting?

NCT01290393 is currently terminated. Last updated 26 July 2018.

Last reviewed 2018-07-26 · How we verify

NCT01290393

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

Terminated Last updated 26 July 2018

What this trial tests

trial testing Data collection in Infections, Papillomavirus in 2 participants. Terminated before completion.

Timeline

26 September 2011

Primary endpoint
20 December 2012

20 December 2012

Quick facts

Lead sponsor	GlaxoSmithKline
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	2
Start date	26 September 2011
Primary completion	20 December 2012
Estimated completion	20 December 2012
Sites	1 location across United States

Drugs / interventions tested

Data collection — full drug profile →

Conditions studied

Infections, Papillomavirus — all drugs for Infections, Papillomavirus →

Sponsor

GlaxoSmithKline — full company profile →

Who can join

Adults 15 to 25, female only, with Infections, Papillomavirus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess the risk of spontaneous abortion during weeks 1-19 of gestation, and other pregnancy outcomes, in an Exposed vaccinated cohort, i.e. women with last menstrual period between 30 days before and 90 days after any dose of CERVARIX, when compared to a Non-exposed vaccinated cohort, i.e. women with last menstrual period between 120 days and 18 months after the last CERVARIX or GARDASIL dose.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Data collection

Trials testing the same drug.

NCT07010562 — A Multi-site, Pre-clinical, Prospective Data Collection Study in Patients Undergoing a Right Heart Catheterization · not yet recruiting
NCT07418359 — Comparison of Patient's Physical Activity Levels According to the Physical Activity Level of Their General Practitioner · recruiting
NCT07197398 — Preoperative Data and the Spinal Spread of Local Anesthetic in Cesarean Section · recruiting
NCT06998797 — Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study · not yet recruiting
NCT07529730 — Outcomes of Surgical Treatment in Patients With Infective Endocarditis · completed

Other GlaxoSmithKline trials

Trials by the same sponsor.

NCT07569081 — A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflam · Phase 2, PHASE3 · not yet recruiting
NCT07406347 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose · Phase 1 · not yet recruiting
NCT07286266 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEH · Phase 3 · not yet recruiting
NCT07286331 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-E · Phase 3 · not yet recruiting
NCT07406334 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01290393 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GlaxoSmithKline
Last refreshed: 26 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01290393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing